Currently employed | Employment discontinued | P-value* | |
---|---|---|---|
Age (years) | n = 811 | n = 998 | |
18 - 21 | 59 (57.3%) | 44 (42.7%) | |
22 - 29 | 153 (49.8%) | 154 (50.2%) | |
30 - 39 | 265 (51.5%) | 250 (48.5%) | |
40 - 49 | 202 (42.9%) | 269 (57.1%) | |
50 - 59 | 119 (34.6%) | 225 (65.4%) | |
60+ | 13 (18.8%) | 56 (81.2%) | < 0.001 |
Sex | n = 811 | n = 998 | |
Female | 643 (46.4%) | 743 (53.6%) | |
Male | 168 (39.7%) | 255 (60.3%) | 0.02 |
Duration of illness (months) | n = 743 | n = 878 | |
Median (IQR) | 35 (15 - 84) | 48 (18 - 120) | < 0.001 |
Chalder Fatigue (0 - 33) | n = 752 | n = 911 | |
Median (IQR) | 25 (21 - 30) | 27 (23 - 31) | < 0.001 |
SF-36 physical function (scale 0 - 100) | n = 744 | n = 901 | |
Median (IQR) | 50 (35 - 65) | 30 (20 - 45) | < 0.001 |
HADS anxiety (scale 0 - 21) | n = 751 | n = 916 | |
Median (IQR) | 10 (7 - 13) | 11 (7 - 14) | 0.02 |
HADS depression (scale 0 - 21) | n = 753 | n = 919 | |
Median (IQR) | 9 (6 - 12) | 10 (7 - 13) | < 0.001 |
Visual Analogue Pain (scale 0 - 100) | n = 717 | n = 886 | |
Median (IQR) | 43 (18 - 65) | 55 (26 - 72) | < 0.001 |